Aumann, S.; Shaulov, A.; Haran, A.; Gross Even-Zohar, N.; Vainstein, V.; Nachmias, B.
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2022, 23, 10957.
https://doi.org/10.3390/ijms231810957
AMA Style
Aumann S, Shaulov A, Haran A, Gross Even-Zohar N, Vainstein V, Nachmias B.
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2022; 23(18):10957.
https://doi.org/10.3390/ijms231810957
Chicago/Turabian Style
Aumann, Shlomzion, Adir Shaulov, Arnon Haran, Noa Gross Even-Zohar, Vladimir Vainstein, and Boaz Nachmias.
2022. "The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia" International Journal of Molecular Sciences 23, no. 18: 10957.
https://doi.org/10.3390/ijms231810957
APA Style
Aumann, S., Shaulov, A., Haran, A., Gross Even-Zohar, N., Vainstein, V., & Nachmias, B.
(2022). The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences, 23(18), 10957.
https://doi.org/10.3390/ijms231810957